ZC2HC1B

gene
On this page

Also known as dJ468K18.5

Summary

ZC2HC1B (zinc finger C2HC-type containing 1B, HGNC:21174) is a protein-coding gene on chromosome 6q24.2, encoding Zinc finger C2HC domain-containing protein 1B (Q5TFG8).

Predicted to enable zinc ion binding activity.

Source: NCBI Gene 153918 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 36 total
  • MANE Select transcript: NM_001013623

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21174
Approved symbolZC2HC1B
Namezinc finger C2HC-type containing 1B
Location6q24.2
Locus typegene with protein product
StatusApproved
AliasesdJ468K18.5
Ensembl geneENSG00000118491
Ensembl biotypeprotein_coding
Entrez153918

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000237275, ENST00000539295

RefSeq mRNA: 1 — MANE Select: NM_001013623 NM_001013623

CCDS: CCDS47495

Canonical transcript exons

ENST00000237275 — 8 exons

ExonStartEnd
ENSE00001620516143938142143938343
ENSE00003553684143884304143884365
ENSE00003588160143886032143886151
ENSE00003591001143864474143864567
ENSE00003654836143886683143886821
ENSE00003755440143937649143937733
ENSE00003755770143898552143898691
ENSE00003757639143903044143903152

Expression profiles

Bgee: expression breadth broad, 64 present calls, max score 92.17.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0434 / max 34.7335, expressed in 3 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
702700.03633
702710.00443
702690.00272

Top tissues by expression

92 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047392.17silver quality
left testisUBERON:000453381.49gold quality
testisUBERON:000047380.92gold quality
right testisUBERON:000453479.81gold quality
placentaUBERON:000198749.22gold quality
ventricular zoneUBERON:000305345.74gold quality
skeletal muscle tissueUBERON:000113443.50gold quality
bone marrow cellCL:000209242.86gold quality
lower esophagus mucosaUBERON:003583442.58silver quality
vermiform appendixUBERON:000115442.53gold quality
colonic epitheliumUBERON:000039742.38gold quality
muscle tissueUBERON:000238541.62gold quality
calcaneal tendonUBERON:000370141.53gold quality
endometriumUBERON:000129541.41gold quality
hindlimb stylopod muscleUBERON:000425241.25gold quality
lymph nodeUBERON:000002940.76gold quality
skin of abdomenUBERON:000141639.41gold quality
lower esophagus muscularis layerUBERON:003583339.10gold quality
lower esophagusUBERON:001347338.92gold quality
sural nerveUBERON:001548838.68gold quality
tonsilUBERON:000237238.38silver quality
apex of heartUBERON:000209837.73silver quality
esophagogastric junction muscularis propriaUBERON:003584137.32gold quality
smooth muscle tissueUBERON:000113537.04gold quality
subcutaneous adipose tissueUBERON:000219037.03gold quality
zone of skinUBERON:000001436.71gold quality
esophagusUBERON:000104336.63gold quality
monocyteCL:000057636.53silver quality
cortical plateUBERON:000534336.47gold quality
endocervixUBERON:000045836.21silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.99

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

14 targeting ZC2HC1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4673100.0066.641490
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-6772-5P99.9467.01577
HSA-MIR-3140-3P99.8868.472069
HSA-MIR-205299.7969.372031
HSA-MIR-444199.4966.563216
HSA-MIR-155-5P99.3570.161509
HSA-MIR-10522-5P99.2668.502087
HSA-MIR-6734-3P99.1566.271627
HSA-MIR-427099.0266.261987
HSA-MIR-6754-5P98.6065.541627
HSA-MIR-397798.0068.171500
HSA-MIR-6815-5P96.0565.55662
HSA-MIR-6865-5P96.0565.58675

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusZc2hc1bENSMUSG00000019815
rattus_norvegicusZc2hc1bENSRNOG00000042705
drosophila_melanogasterCG30460FBGN0050460
drosophila_melanogasterCG42675FBGN0261561
caenorhabditis_elegansWBGENE00020196

Paralogs (3): ZC2HC1A (ENSG00000104427), ZNF474 (ENSG00000164185), ZNF475 (ENSG00000250803)

Protein

Protein identifiers

Zinc finger C2HC domain-containing protein 1BQ5TFG8 (reviewed: Q5TFG8)

All UniProt accessions (1): Q5TFG8

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the ZC2HC1 family.

RefSeq proteins (1): NP_001013645* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026319ZC2HC1A/B-likeFamily
IPR049899Znf_C2HC_C3HDomain

Pfam: PF13913

UniProt features (10 total): binding site 4, zinc finger region 2, region of interest 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5TFG8-F174.420.32

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 18; 21; 33; 37

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 16 (showing top): PAX3_TARGET_GENES, MIR2052, MIR3140_3P, MIR155_5P, MIR6865_5P, MIR6815_5P, MIR6772_5P, GSE13306_TREG_VS_TCONV_DN, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN, DESCARTES_MAIN_FETAL_SATELLITE_CELLS, GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN, chr6q24, GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN, GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN, GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN

GO Biological Process (0):

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transition metal ion binding1
binding1
cation binding1

Protein interactions and networks

STRING

194 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZC2HC1BFAM163BP0C2L3735
ZC2HC1BSEC22CQ9BRL7666
ZC2HC1BZDHHC22Q8N966646
ZC2HC1BLRRTM2O43300508
ZC2HC1BZNF496Q96IT1439
ZC2HC1BTSC22D4Q9Y3Q8419
ZC2HC1BPHACTR2O75167384
ZC2HC1BSF3B5Q9BWJ5372
ZC2HC1BPLAGL1Q9UM63372
ZC2HC1BLTV1Q96GA3365
ZC2HC1BYJEFN3A6XGL0348
ZC2HC1BRNF145Q96MT1345
ZC2HC1BADAT2Q7Z6V5342
ZC2HC1BFUCA2Q9BTY2323
ZC2HC1BACADSP16219323

IntAct

23 interactions, top by confidence:

ABTypeScore
NCK2ZC2HC1Bpsi-mi:“MI:0915”(physical association)0.560
NFKBIDZC2HC1Bpsi-mi:“MI:0915”(physical association)0.560
GABPAZC2HC1Bpsi-mi:“MI:0915”(physical association)0.560
ZC2HC1BNFKBIDpsi-mi:“MI:0915”(physical association)0.560
ZC2HC1BZGPATpsi-mi:“MI:0915”(physical association)0.560
ZC2HC1BCASTOR1psi-mi:“MI:0915”(physical association)0.560
ZC2HC1BTUFMpsi-mi:“MI:0915”(physical association)0.400
CFTRZC2HC1Bpsi-mi:“MI:0915”(physical association)0.370
CACNG1TMEM120Bpsi-mi:“MI:0914”(association)0.350
REP15MCM3APpsi-mi:“MI:0914”(association)0.350
OR2M7MARCHF6psi-mi:“MI:0914”(association)0.350
ZC2HC1BTUBB4Apsi-mi:“MI:0914”(association)0.350
OR52K2ZC2HC1Bpsi-mi:“MI:0914”(association)0.350
ZGPATZC2HC1Bpsi-mi:“MI:0915”(physical association)0.000
GABPAZC2HC1Bpsi-mi:“MI:0915”(physical association)0.000
CASTOR1ZC2HC1Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (27): ZC2HC1B (Two-hybrid), GABPA (Two-hybrid), NFKBID (Two-hybrid), ZGPAT (Two-hybrid), GATSL3 (Two-hybrid), ZC2HC1B (Proximity Label-MS), ZC2HC1B (Affinity Capture-MS), ZC2HC1B (Affinity Capture-MS), TUBB4A (Affinity Capture-MS), TUBB4B (Affinity Capture-MS), TUBB (Affinity Capture-MS), TUBB8 (Affinity Capture-MS), ZC2HC1B (Affinity Capture-MS), ZC2HC1B (Affinity Capture-MS), TUBB2A (Affinity Capture-MS)

ESM2 similar proteins: A0JMZ1, A1L209, A1L2F3, A1L3I5, A2AWT3, A4FUE7, A6QQM4, O82171, O94519, P97868, Q08AZ1, Q14CW9, Q1W1G1, Q22122, Q2HJG4, Q2YDJ0, Q32KN7, Q5EAW4, Q5PPV5, Q5REC0, Q5TFG8, Q5ZMS6, Q618K0, Q62920, Q64GL0, Q66HC1, Q6DGN6, Q6NRP6, Q6P1U3, Q6V5K9, Q7SXT7, Q7Z6E9, Q801E2, Q8BJH1, Q8CI51, Q8H100, Q8IMP6, Q8IYB5, Q8R550, Q91W18

Diamond homologs: A4FUE7, Q22122, Q32KN7, Q53FD0, Q5PPV5, Q5REC0, Q5TFG8, Q618K0, Q6AYP4, Q7SXT7, Q8BJH1, Q8CCG1, Q96GY0, Q9BGW4, Q9D534, Q5R498

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

36 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance32
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1460 predictions. Top by Δscore:

VariantEffectΔscore
6:143886031:GGAAA:Gacceptor_gain1.0000
6:143886147:CCAAG:Cdonor_loss1.0000
6:143886148:CAAGG:Cdonor_loss1.0000
6:143886149:AAGGT:Adonor_loss1.0000
6:143886150:AG:Adonor_loss1.0000
6:143886151:GG:Gdonor_loss1.0000
6:143886152:GT:Gdonor_loss1.0000
6:143886153:T:Adonor_loss1.0000
6:143886757:GT:Gdonor_gain1.0000
6:143898545:C:Gacceptor_gain1.0000
6:143898550:A:AGacceptor_gain1.0000
6:143898551:G:GAacceptor_gain1.0000
6:143898551:GATT:Gacceptor_gain1.0000
6:143903043:GGGTA:Gacceptor_gain1.0000
6:143903148:GTCAG:Gdonor_gain1.0000
6:143903150:CAGG:Cdonor_loss1.0000
6:143903150:CAGGT:Cdonor_loss1.0000
6:143903152:GGT:Gdonor_loss1.0000
6:143903153:GT:Gdonor_loss1.0000
6:143903153:GTG:Gdonor_loss1.0000
6:143903154:T:Adonor_loss1.0000
6:143903154:T:Gdonor_loss1.0000
6:143937645:AAAG:Aacceptor_gain1.0000
6:143937646:A:Gacceptor_gain1.0000
6:143867018:GTA:Gdonor_gain0.9900
6:143867019:TAT:Tdonor_gain0.9900
6:143867020:ATA:Adonor_gain0.9900
6:143886026:TTCTA:Tacceptor_loss0.9900
6:143886028:CTA:Cacceptor_loss0.9900
6:143886029:TA:Tacceptor_loss0.9900

AlphaMissense

1446 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:143884348:T:CF25L0.925
6:143884350:T:AF25L0.925
6:143884350:T:GF25L0.925
6:143886083:T:CF48L0.887
6:143886085:C:AF48L0.887
6:143886085:C:GF48L0.887
6:143898584:T:CF128L0.777
6:143898586:T:AF128L0.777
6:143898586:T:GF128L0.777
6:143898647:T:CF149L0.766
6:143898649:T:AF149L0.766
6:143898649:T:GF149L0.766
6:143898617:T:CF139L0.754
6:143898619:C:AF139L0.754
6:143898619:C:GF139L0.754
6:143886062:T:CF41L0.749
6:143886064:C:AF41L0.749
6:143886064:C:GF41L0.749
6:143884349:T:CF25S0.710
6:143886709:G:CW79C0.707
6:143886709:G:TW79C0.707
6:143884349:T:GF25C0.695
6:143884344:A:CR23S0.687
6:143884344:A:TR23S0.687
6:143886728:T:CF86L0.676
6:143886730:T:AF86L0.676
6:143886730:T:GF86L0.676
6:143886103:A:CR54S0.647
6:143886103:A:TR54S0.647
6:143886048:T:AI36K0.636

dbSNP variants (sampled 300 via entrez): RS1000012741 (6:143913438 C>T), RS1000019628 (6:143916933 G>A,C), RS1000080719 (6:143925974 T>G), RS1000083456 (6:143880718 A>G), RS1000119260 (6:143927045 G>A,C,T), RS1000133848 (6:143887628 A>G), RS1000182367 (6:143887114 A>G), RS1000206287 (6:143931469 T>C,G), RS1000241657 (6:143918796 A>G,T), RS1000361289 (6:143876747 G>A), RS1000361872 (6:143893831 C>T), RS1000433487 (6:143938107 A>G), RS1000449459 (6:143864622 C>G), RS1000466911 (6:143883960 G>A), RS1000475693 (6:143885404 A>C,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002594_29Neurofibrillary tangles3.000000e-06
GCST007637_43Diffusing capacity of carbon monoxide4.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0006797neurofibrillary tangles measurement
EFO:0009369diffusing capacity of the lung for carbon monoxide

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases methylation2
Nickeldecreases expression2
benzo(e)pyreneincreases methylation1
aflatoxin B2decreases methylation1
Methapyrileneincreases methylation1
Antirheumatic Agentsincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.